Pulmonary Disease: Treatment and Critical Care

Dear Colleagues,

Pulmonary disease has been the main focus of research during recent years, especially in the COVID-19 pandemic era which the world has experienced, and the scientific community has struggled to resolve therapeutic dilemmas facing the most vulnerable patients. The diversity of pathophysiological mechanisms underlying pulmonary infections such as community-acquired pneumonia, healthcare-acquired pneumonia, and acute respiratory distress syndrome have called for the individualization of treatments. Moreover, patients with acute respiratory failure may experience complications related to cardiomyopathy and heart failure. It is increasingly clear that cellular and molecular mechanisms should be considered for an optimal therapeutic approach. Classical treatment protocols have been questioned and novel treatment algorithms are evaluated for the management of patients with lung infections, chronic obstructive lung disease, and interstitial pneumonias. The treatment of pulmonary embolism is rather challenging in critically ill patients, considering the altered hemostasis mechanisms that are present. This Special Issue entitled “Pulmonary Disease: Treatment and Critical Care” focuses on patients with pulmonary disease that warrant critical care management. We warmly welcome a broad assortment of submissions, including original papers and reviews, covering areas on the use of mechanical ventilation, extracorporeal treatment modalities and pharmacological treatments to manage pulmonary disease.

Dr. Vasiliki Tsolaki
Dr. Eleni Massa
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-anonymized peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.